The effects of the gonadotrophin releasing hormone analogue (goserelin) and prostaglandin E1 (misoprostol) on cervical resistance prior to transcervical resection of the endometrium

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 4, 1996, Pages 375-378

  Cooper, K G ^a   Pinion, S B ^b   Bhattacharya, S ^a   Parkin, D E ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS FIFE   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; GOSERELIN; MISOPROSTOL; PROSTAGLANDIN E1;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DRUG EFFECT; FEMALE; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX; UTERUS BLEEDING;

CERVIX UTERI; DILATATION; ENDOMETRIUM; FEMALE; GOSERELIN; HUMANS; LASER SURGERY; MISOPROSTOL; OXYTOCICS; PREOPERATIVE CARE;

EID: 0029979284     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09746.x     Document Type: Article

References (8)

1. Pinion SB, Parkin DE, Abramovich DR et al. Randomised trial of hysterectomy, endometrial laser ablation and transcervical resection for dysfunctional uterine bleeding. BMJ 1994; 309: 979-983.
2. Goldrath MH. Use of danazol in hysteroscopic surgery for menorrhagia. J Reprod Med 1990; 35: 91-96.
3. Whittaker M, Garry R. A prospective randomised study comparing Zoladex and Danazol in preparing the endometrium for laser ablation in women with dysfunctional uterine bleeding [abstract]. Proceedings of the British Society of Gynaecological Endoscopy Annual Meeting; 1994 Nov 4-5; Queen Elizabeth Postgraduate Medical Centre, Birmingham.
4. Scottish Hysteroscopy Audit Group. A Scottish audit of hysteroscopic surgery for menorrhagia: Complications and follow up. Br J Obstet Gynaecol 1995; 102: 249-254.
5. Hald F, Kristofferson SE, Gregersen E. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy. Acta Obstet Gynecol Scand 1988; 67: 219-222.
6. Rabe, T, Willinger, G, Kiesel, L et al. Study of the 16,16′-dimethyl-trans-delta 2 prostaglandin El methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal women. Adv Contracept 1985; 1: 91-102.
7. Anthony GS, Fisher J, Coutts JR, Calder AA. Forces required for surgical dilatation of the pregnant and non-pregnant human cervix. Br J Obster Gynaecol 1982; 89: 913-916.
8. Thomas EJ, Jenkins J, Lenton EA, Cooke ID. Endocrine effects of goserelin, a depot luteinising hormone releasing hormone analogue. BMJ 1986; 293: 1407-1408.